Predoctoral Training Grant in Pharmacology

药理学博士前培训补助金

• 批准号: 10657560
• 负责人: Julie A Blendy
• 金额: $ 63.66万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 1984
• 资助国家: 美国
• 起止时间: 1984-07-01 至 2024-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10657560
• 关键词: Grant; Pharmacology; Training; pre-doctoral

The Pharmacology Graduate Training Program's mission is to prepare PhD scientists in fields of pharmacology for careers in academic and industrial research, governmental agencies and a variety of professional paths Our mission is accomplished by training our Ph.D. students to be critical thinkers, embracing innovation and creativity to advance scholarship and scientific discovery. This training program is the only one at the University of Pennsylvania that trains predoctoral graduate students in fundamentals of Pharmacology. Current areas of research and training in the PGG are Neuropharmacology, Cell Signaling, Pharmacological Chemistry, Cancer Pharmacology, Cardiovascular Pharmacology, Pharmacogenetics, Environmental Toxicology, and Translational Medicine. The PGG offers 14 graduate-level courses in Pharmacology and two recently developed workshops on “Professional Skills” and “Grant Writing/Candidacy Exam” preparation. Over the past five years the total number of students in the program has remained relatively constant with the current census at 68 (64 TGE) and the number of faculty trainers has remained near 60. Due to the training requirements associated with the training program, all predoctoral trainees supported by the training grant are in the PGG. We request support for 12 predoctoral training positions for the next 5 years. The pool of students available for appointment to the training program comprises all US residents or students with permanent resident status in the PGG. We support students for one to two years in Year 2 and 3 as most coursework and training workshops occurs during these years however all students supported with this training program continue to participate and enjoy the training related activities until awarding of their PhD.

药理学研究生培训计划的使命是准备博士学位 在学术和工业研究领域的药理学领域的科学家， 政府机构和各种专业道路，我们的任务已完成 通过培训我们的博士学位学生成为批判性思想家，拥抱创新和创造力 推进科学和科学发现。该培训计划是唯一一个 宾夕法尼亚大学培训基础知识前研究生 药理学。 PGG中的当前研究和培训领域是 神经药理学，细胞信号传导，药理学化学，癌症药理学， 心血管药理学，药物遗传学，环境毒理学和 翻译医学。 PGG提供了14个药理学和 最近有两个有关“专业技能”和“授予写作/候选资格的讲习班” 考试“准备”。在过去五年中，该计划中的学生总数 在68（64 TGE）的当前人口普查中保持相对恒定 教师培训师的数量已接近60。由于培训要求 与培训计划相关联，所有受培训支持的冠军学员 格兰特在PGG中。我们要求支持12个专长培训职位 接下来的5年。可任命培训计划的学生池 包括所有在PGG中具有永久居民身份的美国居民或学生。我们 在第2年和第三年为学生提供一到两年的支持，作为大多数课程和培训 在这些年中举行了研讨会，但是所有学生都支持此培训 计划继续参与并享受与培训相关的活动，直到授予 他们的博士学位。

项目成果

Glucose Challenge Uncovers Temporal Fungibility of Metabolic Homeostasis Throughout the Day.

葡萄糖挑战揭示了全天代谢稳态的时间可替代性。

• DOI: 10.1101/2023.10.30.564837
• 发表时间: 2023
• 期刊: bioRxiv : the preprint server for biology
• 作者: Malik,DaniaM;Rhoades,SethD;Zhang,ShirleyL;Sengupta,Arjun;Barber,Annika;Haynes,Paula;Arnadottir,ErnaSif;Pack,Allan;Kibbey,RichardG;Sehgal,Amita;Weljie,AalimM
• 通讯作者: Weljie,AalimM

USP6 Confers Sensitivity to IFN-Mediated Apoptosis through Modulation of TRAIL Signaling in Ewing Sarcoma.

• DOI: 10.1158/1541-7786.mcr-18-0289
• 发表时间: 2018-12
• 期刊: Molecular cancer research : MCR
• 作者: Henrich IC;Young R;Quick L;Oliveira AM;Chou MM
• 通讯作者: Chou MM

The effects of the covalent attachment of 3-(4-hydroxy-3,5-di-tert-butylphenyl) propyl amine to glutaraldehyde pretreated bovine pericardium on structural degeneration, oxidative modification, and calcification of rat subdermal implants.

• DOI: 10.1002/jbm.a.35380
• 发表时间: 2015-07
• 期刊: JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
• 影响因子: 4.9
• 作者: Christian, Abigail J.;Alferiev, Ivan S.;Connolly, Jeanne M.;Ischiropoulos, Harry;Levy, Robert J.
• 通讯作者: Levy, Robert J.

Metal speciation in health and medicine represented by iron and vanadium.

• DOI: 10.1021/ic4007873
• 发表时间: 2013-09
• 期刊: Inorganic chemistry
• 影响因子: 4.6
• 作者: D. Crans;Kellie A. Woll;Kestutis Prusinskas;Michael D. Johnson;E. Norkus

PARkinson's: From cellular mechanisms to potential therapeutics.

• DOI: 10.1016/j.pharmthera.2021.107968
• 发表时间: 2022-03
• 期刊: Pharmacology & therapeutics
• 影响因子: 13.5
• 作者: Lengyel-Zhand Z;Puentes LN;Mach RH
• 通讯作者: Mach RH